According to the US Office for Human Research Protections, paying individuals to participate in research is “a common and, in general, acceptable practice.” At the same time, both the Common Rule and FDA regulations instruct researchers and IRBs to minimize the possibility of coercion and undue influence during informed consent, which has often been interpreted as placing limits on acceptable payment amounts.
In this webinar, Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues involved in paying research subjects.
1. Analyze case studies aimed at drawing out challenging ethical and regulatory aspects of paying research subjects.
2. Define the key regulatory terms of “coercion” and ”undue influence” and the main risk of payment in relation to these concepts.
3. Describe and apply a practical framework for evaluating payment that stresses the importance of being clear about why payment is being offered: as reimbursement, compensation, or recruitment incentive.
Content applies to:
- IRB members of any experience level
- Principal investigators and research staff
- Site and sponsor personnel (and others) involved with proposing payment amounts or setting policy around payment
Note: This webinar is a collaboration between Advarra and Forte. We are in the process of integrating our webinar programs, and as a result we’re offering just one broadcast date for our March webinar. Certificates of attendance are available for this broadcast. Can't make it March 31? You should still register—we'll send a recording link to all registrants after the broadcast.